当前位置: X-MOL 学术Nat. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial
Nature Medicine ( IF 58.7 ) Pub Date : 2024-11-15 , DOI: 10.1038/s41591-024-03404-w
Steven M. Horwitz, Ajit J. Nirmal, Jahan Rahman, Ran Xu, Esther Drill, Natasha Galasso, Nivetha Ganesan, Theresa Davey, Helen Hancock, Leslie Perez, Catherine Maccaro, Alexandra Bahgat, Evan Marzouk, Elizabeth Cathcart, Alison Moskowitz, Ariela Noy, Anita Kumar, Eric Jacobsen, David C. Fisher, Neha Mehta-Shah, Youn H. Kim, Michael Khodadoust, Nikita Kotlov, Anastasia Nikitina, Olga Kudryashova, Valeria Zubareva, Ksenia Zornikova, Nara Shin, Maria Sorokina, Sandrine Degryse, Ekaterina Postovalova, Aleksander Bagaev, Kinga Hosszu, Devin McAvoy, Jaap J. Boelens, Wenchao Wu, Zoe Ciantra, Jackson W. Appelt, Christopher Trevisani, Sam Amaka, David M. Weinstock, Santosha A. Vardhana

Correction to: Nature Medicine https://doi.org/10.1038/s41591-024-03076-6, published online 17 June 2024.

更新日期:2024-11-16
down
wechat
bug